-
November 1: The Week in Cancer News
Another drug shows preliminary signs of efficacy in treating patients with KRAS-mutated cancer, and a study indicates that minority cancer patients struggle to find doctors who share or understand their culture.
by Kate Yandell
-
Learning the Language of Chemotherapy
Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
-
Navigating Hospital Discharge Decisions
Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.
by Ashley P. Taylor
-
October 25: The Week in Cancer News
A physician writes about her experiences treating patients with CAR-T cell therapy, and the U.S. Food and Drug Administration expands approval of an ovarian cancer drug based on a new biomarker.
by Kate Yandell
-
October 18: The Week in Cancer News
A chemotherapy drug used to treat childhood cancer is in short supply, and organizations update exercise recommendations for people who have been diagnosed with cancer.
by Kate Yandell
-
Misunderstandings About Cancer DNA Tests
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
-
October 11: The Week in Cancer News
A researcher with melanoma writes about his experiences trying to modify his gut microbiome, and an article discusses what it means to call a cancer treatment “well tolerated.”
by Kate Yandell
-
Cancer Patients Should Receive Flu Shots
People with cancer are at increased risk of serious complications if they get the flu. Flu shots are safe for this group, and a recent study bolsters evidence of their effectiveness.
by Carly Weeks
-
October 4: The Week in Cancer News
More than half of patients with advanced melanoma who took an immunotherapy combination were alive five years later, and a targeted therapy appears to cause high blood pressure.
by Kate Yandell
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona